Advertisement
Hydroxychloroquine administered for eight weeks as preexposure prophylaxis has no clinical benefit in hospital-based health care workers exposed to patients with COVID-19

Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis

0
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
A daily

Daily Aspirin May Up Growth, Spread of Cancers in Older Adults

0
Authors caution that daily low-dose aspirin is linked to more late-stage cancers, related deaths in elderly
Adjuvant radiotherapy does not improve event-free survival in men with localized or locally advanced prostate cancer treated with radical prostatectomy

Adjuvant Radiotherapy No Better for Localized Prostate Cancer

0
Event-free survival not improved with use of adjuvant versus early salvage radiotherapy
Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or medicine for major contributions to the fight against blood-borne hepatitis.

Three Scientists Share Nobel Prize for Hepatitis C Research

0
Nobel Committee described their work as 'a landmark achievement in our battle against viral infections'
Greater nurse staffing and intensivist hours are associated with significantly lower rates of sepsis

Nursing, Intensivist Staffing Tied to Lower Hospital Sepsis Rates

0
In contrast, greater physician staffing, hospitalist hours associated with higher sepsis rates
Nivolumab combined with cabozantinib is superior to sunitinib alone for the treatment of advanced clear cell renal cell carcinoma

Immunotherapy Combo Treats Advanced Kidney Cancer

0
First results show survival benefit with nivolumab plus cabozantinib versus sunitinib
There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ

Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death

0
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis
Antibodies decrease with time after COVID-19 symptom onset

Antibodies Decrease With Time After COVID-19 Symptom Onset

0
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation
For patients with non-small cell lung cancer with programmed death ligand 1 expression

Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression

0
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
Quadrivalent human papillomavirus vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer

HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk

0
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30